Skip to main content

PathogenDx Inc. Honored on the 2022 Inc. 5000 Annual List

By: Newsfile

PathogenDx Receives Rank No. 1232 Among America's Fastest-Growing Private Companies

Scottsdale, Arizona--(Newsfile Corp. - August 16, 2022) - Inc. revealed that PathogenDx ("PathogenDx" or "Company"), a leader in world-class microarray technology to advance molecular testing in human diagnostics, food and agricultural industries, placed No. 1232 on the annual Inc. 5000 list, the most prestigious ranking of the fastest-growing private companies in America. The list takes a one-of-a-kind look at the most successful companies within the economy's most dynamic segment-its independent businesses. Facebook, Chobani, Under Armour, Microsoft, Patagonia and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

"We are honored to be named one of the fastest-growing private companies in Inc. 5000," said PathogenDx Co-founder and CEO Milan Patel. "This recognition is a function of the level of innovation and commercial growth we drive day-in and day-out at PathogenDx. I couldn't be more proud of our incredible team of molecular scientists, who have developed testing systems intended for better health and safety. Using our next-generation microarray technology, our scientists have advanced molecular testing to enable the interrogation of multiple targets with speciation in the same reaction across sample types."

Patel added, "Our assays deliver single gene copy sensitivity and single nucleotide resolution, driving efficiencies at very low costs while delivering high sample volume sequencing level accuracy for the human diagnostics, food safety, agricultural and the environment monitoring markets. We are pushing the envelope so that we can truly address some of the world's greatest challenges in pathogen infection and contamination, whether it's related to our food or agricultural systems, our water or beyond. Health and safety is in all of our best interest, and we are proud to be recognized for our passion and our efforts to secure a safer world for everyone."

The companies on the 2022 Inc. 5000 have not only been successful, but have also demonstrated resilience amid supply chain woes, labor shortages, and the ongoing impact of Covid-19. Among the top 5000, the average median three-year revenue growth rate soared to 2,144 percent. Together, those companies added more than 68,394 jobs over the past three years. Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region and other criteria, can be found at www.inc.com/inc5000.

"The accomplishment of building one of the fastest-growing companies in the U.S., in light of recent economic roadblocks, cannot be overstated," says Scott Omelianuk, editor-in-chief of Inc. "Inc. is thrilled to honor the companies that have established themselves through innovation, hard work, and rising to the challenges of today."

Additionally, PathogenDx was ranked No. 46 in Inc. Magazine's List of the Southwest Region's Fastest-Growing Private Companies in March 2022, and was also named in Fast Company's World Changing Ideas Awards 2021: Pandemic Response Finalists and Honorable Mentions for innovating through its introduction of an expanded 96-well plate microarray, with improved sample preparation and streamlined data reporting and the introduction of a new, customized data analysis portal. The company recently launched an 'Industry first' multiplex assay for rapid, affordable variant detection for SARS-CoV-2 with unmatchable capability to identify emerging variants and mutations. The company's National Institute of Health ("NIH")-supported technology would provide invaluable insight to guide scientific discovery and public health decision making - not someday, but today - and does so without the time and expense of sequencing.

CONTACT:
Michela Proto
914-907-3670
pathogendx@mattio.com

More about Inc. and the Inc. 5000

Methodology

Companies on the 2022 Inc. 5000 are ranked according to percentage revenue growth from 2018 to 2021. To qualify, companies must have been founded and generating revenue by March 31, 2018. They must be U.S.-based, privately held, for-profit, and independent-not subsidiaries or divisions of other companies-as of December 31, 2021. (Since then, some on the list may have gone public or been acquired.) The minimum revenue required for 2018 is $100,000; the minimum for 2021 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Growth rates used to determine company rankings were calculated to four decimal places. The top 500 companies on the Inc. 5000 are featured in Inc. magazine's September issue. The entire Inc. 5000 can be found at http://www.inc.com/inc5000.

About Inc.

The world's most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multiplatform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference & Gala is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit www.inc.com.

For more information on the Inc. 5000 Conference & Gala, visit http://conference.inc.com/.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/133950

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.